Skip to content

Bausch Health Companies BHC Payments for Legal Settlements

Payments for Legal Settlements at other companies

Bausch + Lomb logo
Bausch + LombBLCO

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForLegalSettlements.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's payments for legal settlements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's payments for legal settlements?
Bausch Health Companies (BHC) reported payments for legal settlements of $161M in Q1 2026.
How has Bausch Health Companies's payments for legal settlements changed year-over-year?
Bausch Health Companies's payments for legal settlements increased by 747.4% year-over-year, from $19M to $161M.
What is the long-term trend for Bausch Health Companies's payments for legal settlements?
Over 3 years (2021 to 2025), Bausch Health Companies's payments for legal settlements has grown at a -15.1% compound annual growth rate (CAGR), from $351M to $215M.
What does payments for legal settlements mean?
Represents the actual cash outflow associated with resolving legal disputes and regulatory claims. Monitoring this metric is essential for assessing the company's ongoing litigation risk and its impact on liquidity.